JMP Securities has decided to maintain its Outperform rating of Inhibrx (NASDAQ:INBX) and lower its price target from $35.00 to $27.00.
Shares of Inhibrx are trading up 0.71% over the last 24 hours, at $19.20 per share.
Support authors and subscribe to content
This is premium stuff. Subscribe to read the entire article.
Login if you have purchased